Navigation Links
Drug companies in India keen on developing bird flu drug

The government is likely to invoke the compulsory licensing (CL) provision in the Patents Act that would enable domestic drug //firms to produce and stockpile Swiss drug maker Roche’s patented drug Tamiflu, useful in combating the global threat against the most dreaded avian flu virus.

Section 92 empowers the government to issue CL without receipt of an application from the industry. Furthermore, the issue of such license is independent of third party consent. The following proposal is expected to help cope up with a public health emergency that might arise in case the pandemic hits India. Once compulsory licensing has been issued, manufacture of the drug can be initiated, to ensure both domestic and international supply.

The drug companies in India are more than willing to participate in the initiative. Ranbaxy Laboratories has already initiated talks with the Swiss pharma company regarding the issue. The company is also getting in touch with governments across the world, interested in sourcing the drug from it.

The situation would however require a critical analysis of patents issue across the world. It would be six months before the drug can actually be manufactured following regulatory approvals.

In response to the above situation, Roche has announced it would not welcome interventions by generic drug makers in Tamiflu market, the demand for which has increased manifold following reports that the pandemic has reached Europe and SE Asia.

Medindia on Bird Flu:

Avian influenza (AI) or Bird Flu is a disease of viral etiology that ranges from a mild or even asymptomatic infection to an acute, fatal disease of chickens, turkeys, guinea fowls, and other avian species, especially migratory waterfowl
'"/>




Page: 1

Related medicine news :

1. India to benefit from pharma companies move
2. Doctors not to accept gifts from drug companies
3. Pharmaceutical companies are targeting patients
4. Historic trial for tuberculosis launched together by leading drug companies
5. Pakistan drug companies seek trade ties with India
6. Depression Accompanies Heart Attacks in Younger Women
7. Cigarette companies adopt devious methods to ensure customer patronage
8. Is Diabetes the Leading Cause of Kidney Failure in India
9. AIDS Disaster in India is Imminent
10. Indian Prime Minister has successful Knee Replacement Surgery
11. International community warns India on HIV situation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... ... May 04, 2016 , ... The RIDER ... and development of DRACO broad-spectrum antiviral therapeutics. DRACOs have proven effective against all ... May 3, 2016 at http://igg.me/at/EndTheVirus and runs for 60 days, we ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... Nike Rugby ... junior rugby in San Diego. Willis, founder of Elite Rugby Camps and current Nike ... and players every year since 2009. , “I’m excited for our eighth summer ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... a master charity program created to assist the people of their local community. ... with nonprofit organizations and community leaders. Their hope is to bring awareness to ...
(Date:5/4/2016)... ... May 04, 2016 , ... Dr. Elyson and Dr. Assili, ... surgery at their office. Wisdom tooth removal, a common dental procedure, is performed for ... often are improperly erupted, resulting in risks of complications. By providing wisdom tooth removal ...
(Date:5/4/2016)... ... ... Francesca Loparco, Co-Founder of Queen City Dream Cars, an exotic car rental business ... at Christenbury Eye Center. The entrepreneur struggled with her computer, riding horses and driving ... her in-office consultation and eye exam. Francesca’s eyesight was restored to 20/20 in both ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Actinic Keratosis Market ... to their offering.       (Logo: ... Keratosis Market and Competitive Landscape Highlights 2016, ... products, Actinic Keratosis epidemiology, Actinic Keratosis market ...
(Date:5/3/2016)... Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and increase market presence. ... ... ... ... Sino-German High-Tech Fund ...
(Date:5/3/2016)... Ore. , May 3, 2016   BIOTRONIK ... importance of extending care beyond the implant at the ... May 4-7 in San Francisco . ... continually delivering the highest quality of patient care and ... are cared for each and every tomorrow," said ...
Breaking Medicine Technology: